Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor
Autore:
Garcia-Diaz, JB; Palau, L; Pankey, GA;
Indirizzi:
Alton Ochsner Med Fdn & Ochsner Clin, Dept Infect Dis, New Orleans, LA 70121 USA Alton Ochsner Med Fdn & Ochsner Clin New Orleans LA USA 70121 A 70121 USA Houston NW Med Ctr, Houston, TX USA Houston NW Med Ctr Houston TX USAHouston NW Med Ctr, Houston, TX USA
Titolo Testata:
CLINICAL INFECTIOUS DISEASES
fascicolo: 12, volume: 32, anno: 2001,
pagine: E166 - E170
SICI:
1058-4838(20010615)32:12<E166:RORZAW>2.0.ZU;2-G
Fonte:
ISI
Lingua:
ENG
Soggetto:
ASPERGILLUS-FUMIGATUS HYPHAE; CANDIDA-ALBICANS; INTERFERON-GAMMA; MUCORMYCOSIS; PATIENT;
Tipo documento:
Editorial Material
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
15
Recensione:
Indirizzi per estratti:
Indirizzo: Pankey, GA Alton Ochsner Med Fdn & Ochsner Clin, Dept Infect Dis, 1516 Jefferson Highway, New Orleans, LA 70121 USA Alton Ochsner Med Fdn & Ochsner Clin 1516 Jefferson Highway New Orleans LA USA 70121
Citazione:
J.B. Garcia-Diaz et al., "Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor", CLIN INF D, 32(12), 2001, pp. E166-E170

Abstract

We successfully treated 3 consecutive patients who had nonneutropenic rhinocerebral zygomycosis, by use of subcutaneous granulocyte-macrophage colony-stimulating factor therapy combined with traditional surgical and medical treatment. All patients are currently free of disease. Granulocyte-macrophage colony-stimulating factor should be considered as adjuvant therapy for rhinocerebral zygomycosis; however, optimum dose and length of therapy are unknown.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/03/20 alle ore 19:33:06